:In recent years, the field of nanotechnology has brought about significant advancements that have
transformed the landscape of disease diagnosis, prevention, and treatment, particularly in the realm of medical
science. Among the various approaches to nanoparticle synthesis, the green synthesis method has garnered increasing
attention. Silver nanoparticles (AgNPs) have emerged as particularly noteworthy nanomaterials
within the spectrum of metallic nanoparticles employed for biomedical applications. AgNPs possess several
key attributes that make them highly valuable in the biomedical field. They are biocompatible, cost-effective,
and environmentally friendly, rendering them suitable for various bioengineering and biomedical applications.
Notably, AgNPs have found a prominent role in the domain of cancer diagnosis. Research investigations have
provided evidence of AgNPs' anticancer activity, which involves mechanisms such as DNA damage, cell cycle
arrest, induction of apoptosis, and the regulation of specific cytokine genes. The synthesis of AgNPs primarily
involves the reduction of silver ions by reducing agents. Interestingly, natural products and living organisms
have proven to be effective sources for the generation of precursor materials used in AgNP synthesis. This
comprehensive review aims to summarize the key aspects of AgNPs, including their characterization, properties,
and recent advancements in the field of biogenic AgNP synthesis. Furthermore, the review highlights the
potential applications of these nanoparticles in combating cancer.